Home/ Supplements/ Feverfew/ Full Spectrum Feverfew 380 mg

Full Spectrum Feverfew 380 mg

product on market Capsule Swanson Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • Limited research evidence available for ingredients
B Label Compliance Grade
Label

Product Label

Label for Full Spectrum Feverfew 380 mg
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
100
Servings
Botanical
Product Type
0%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

380 mg
Market median: 380.0mg (120 products) 8 studies — no high-quality reviews

Other Ingredients

Gelatin Magnesium Stearate Silica
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Suggested use: As a dietary supplement, take one capsule one to two times per day with water or as recommended by your healthcare provider.

Warnings & Precautions

Warning: For adults only. Keep out of reach of children.

Do not take this product if you are pregnant or nursing. Consult your healthcare provider before using this or any product if you are taking medication or have a medical condition.

Discontinue use if you experience oral discomfort or skin irritation. Do not use if seal is broken.

Formulation Notes

Supports relaxation and healthy micro-circulation Traditional health-promoting herb Full Spectrum whole herb formula

Supports relaxation

Full Spectrum Feverfew 380 mg per capsule

Additional Information

Store in a cool, dry place.

Metadata

Product Details

UPC / SKU0 87614 11700 3
DSLD Entry Date2024-02-22
Product TypeBotanical
FormCapsule
BrandSwanson
DSLD ID308557
Data Updated2026-04-11
Research

Research Evidence

10
Research Sources
48
Avg Quality
4
Systematic Review
4
Rct
1
Meta Analysis
1
Cochrane Review
B Feverfew for preventing migraine.
Cochrane Review The Cochrane database of systematic reviews PubMed
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2004 PubMed
C Feverfew for preventing migraine
Systematic Review The Cochrane database of systematic reviews 2000 PubMed
C Randomised double-blind placebo-controlled trial of feverfew in migraine prevention
Rct Lancet (London, England) 1988 PubMed
C Feverfew for migraine prophylaxis: a systematic review
Systematic Review Journal of dietary supplements 2009 PubMed DOI
C Tanacetum parthenium and Salix alba (Mig-RL) combination in migraine prophylaxis: a prospective, open-label study
Meta Analysis Clinical drug investigation 2006 PubMed
C The combined effect of acupuncture and Tanacetum parthenium on quality of life in women with headache: randomised study
Rct Acupuncture in medicine : journal of the British Medical Acupuncture Society 2012 PubMed DOI
C A combination of riboflavin, magnesium, and feverfew for migraine prophylaxis: a randomized trial
Rct Headache 2004 PubMed
C Feverfew as a preventive treatment for migraine: a systematic review
Systematic Review Cephalalgia : an international journal of headache 1998 PubMed
D Efficacy of feverfew as prophylactic treatment of migraine
Rct British medical journal (Clinical research ed.) 1985 PubMed
View all evidence for Feverfew →
Compare

Similar Products

Migra-None
Douglas Laboratories · Capsule
100
White Willow Feverfew 350 mg
Eclectic Herb · Capsule
100
Feverfew
GNC Herbal Plus Standardized · Capsule
100
Feverfew
Vitabase · Capsule
100
Feverfew Max-V
Douglas Laboratories · Capsule
100
View all Feverfew products →
Feverfew research Best Feverfew All Feverfew products More from Swanson View on NIH DSLD →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.